Baidu
map

沪医保局简化医疗服务项目管理流程 最短2天患者用上治癌新技术

2019-05-27 佚名 医谷综合报道

近日,上海医保局积极推进“放管服”改革,简化上海新增医疗服务项目管理流程,旨在鼓励医疗新技术更快进入医院使用,更好服务患者。

近日,上海医保局积极推进“放管服”改革,简化上海新增医疗服务项目管理流程,旨在鼓励医疗新技术更快进入医院使用,更好服务患者。

据了解,本次简化流程的最大的亮点是,对于上海市首次开展的医疗服务项目,审核流程所需时间由90个工作日缩短为最长30天。对于已经在上海市开展的医疗服务项目,新增医院开展该项目,审核流程所需时间由90个工作日缩短为2天。

此次调整优化后,价格审核从原来每年审核2-3次,优化为每月审核1次,特殊情况如重大技术创新项目等可以一事一议。同时,“一院一批”改为“统一定价”,对首次应用于上海市临床的新项目,统一制定价格标准,其他医院跟进开展的可免去审价环节,只要向卫生行政部门进行医疗技术临床应用备案,办理完成备案手续后,就可直接按照不超过该项目本市现行价格水平进行收费,无需再申请核价。

上海市第九人民医院“肿瘤冷冻消融治疗技术”得益于上海市医保局近期推进的“放管服”改革。上海交通大学医学院附属第九人民医院财务处长张海斌表示,“肿瘤冷冻消融治疗技术”为治疗肿瘤提供了新的技术手段。按以往的程序,需要每一家想开展的医院获得技术准入,然后再申请开展和收费,需要耗费数月。现在流程大大简化,只要医院有这个新技术的临床应用备案,就可以按照不超过上海市现行价格执行,到上海医保局变更医保信息,2天内就能正常开展这个新技术。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1748874, encodeId=17b51e4887494, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Wed Oct 09 14:10:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903831, encodeId=defa1903831f1, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sat Jan 25 22:10:00 CST 2020, time=2020-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280497, encodeId=6676128049e30, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303610, encodeId=24a2130361066, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586740, encodeId=b1881586e4056, content=<a href='/topic/show?id=0460e60499c' target=_blank style='color:#2F92EE;'>#管理流程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76049, encryptionId=0460e60499c, topicName=管理流程)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a39a17379246, createdName=changfy, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=)]
    2019-10-09 yinhl1990
  2. [GetPortalCommentsPageByObjectIdResponse(id=1748874, encodeId=17b51e4887494, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Wed Oct 09 14:10:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903831, encodeId=defa1903831f1, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sat Jan 25 22:10:00 CST 2020, time=2020-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280497, encodeId=6676128049e30, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303610, encodeId=24a2130361066, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586740, encodeId=b1881586e4056, content=<a href='/topic/show?id=0460e60499c' target=_blank style='color:#2F92EE;'>#管理流程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76049, encryptionId=0460e60499c, topicName=管理流程)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a39a17379246, createdName=changfy, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1748874, encodeId=17b51e4887494, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Wed Oct 09 14:10:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903831, encodeId=defa1903831f1, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sat Jan 25 22:10:00 CST 2020, time=2020-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280497, encodeId=6676128049e30, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303610, encodeId=24a2130361066, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586740, encodeId=b1881586e4056, content=<a href='/topic/show?id=0460e60499c' target=_blank style='color:#2F92EE;'>#管理流程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76049, encryptionId=0460e60499c, topicName=管理流程)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a39a17379246, createdName=changfy, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1748874, encodeId=17b51e4887494, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Wed Oct 09 14:10:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903831, encodeId=defa1903831f1, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sat Jan 25 22:10:00 CST 2020, time=2020-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280497, encodeId=6676128049e30, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303610, encodeId=24a2130361066, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586740, encodeId=b1881586e4056, content=<a href='/topic/show?id=0460e60499c' target=_blank style='color:#2F92EE;'>#管理流程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76049, encryptionId=0460e60499c, topicName=管理流程)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a39a17379246, createdName=changfy, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1748874, encodeId=17b51e4887494, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Wed Oct 09 14:10:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903831, encodeId=defa1903831f1, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sat Jan 25 22:10:00 CST 2020, time=2020-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280497, encodeId=6676128049e30, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303610, encodeId=24a2130361066, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586740, encodeId=b1881586e4056, content=<a href='/topic/show?id=0460e60499c' target=_blank style='color:#2F92EE;'>#管理流程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76049, encryptionId=0460e60499c, topicName=管理流程)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a39a17379246, createdName=changfy, createdTime=Wed May 29 07:10:00 CST 2019, time=2019-05-29, status=1, ipAttribution=)]

相关资讯

福建:新增医疗服务项目试行自主定价

福建省医保办、卫生计生委近日联合印发《福建省新增医疗服务项目价格管理办法》,明确三级医疗机构可根据临床需要申请开展医疗服务新项目并自主定价,以鼓励医疗机构合理使用新技术,更好地满足广大人民群众的医疗服务需求。

Baidu
map
Baidu
map
Baidu
map